RNASE3 and atopic eczema: We believe that the serial determination of ECP levels is useful for monitoring most patients with EoE, given one avoids confounding factors such as infections, acute atopic dermatitis, dietary transgressions or respiratory symptoms, although we are aware that perennial symptoms may hinder the utility of this biomarker in many cases.